Visikol Overview

  • Founded
  • 2012

  • Status
  • Acquired/​Merged

  • Employees
  • 12

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $7.5M

Visikol General Information


Developer of tissue clearing and 3D imaging technology designed to accelerate drug discovery. The company's technology is based on vitro cell culture that leverages the companies technology combined with confocal imaging and quantitative histology to provide 3D in vitro assays which extracts all the data from advanced models, enabling researchers, drug developers and pathologists to capture high-resolution images in 3D from biological tissues.

Contact Information

Ownership Status
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Parent Company
Primary Office
  • 53 Frontage Road
  • Suite 120, Shelbourne Building
  • Hampton, NJ 08827
  • United States
+1 (800) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Visikol Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Merger/Acquisition 20-May-2021 $7.5M 00000 00.00 Completed Generating Revenue
5. Grant 17-Apr-2019 00000 00000 Completed Generating Revenue
4. Early Stage VC 30-Dec-2017 00000 Completed Generating Revenue
3. Grant 31-Dec-2016 0000 00000 Completed Generating Revenue
2. Grant 20-Jun-2016 $225K $500K Completed Generating Revenue
1. Seed Round 23-Feb-2016 $500K $500K 000 Completed Generating Revenue
To view Visikol’s complete valuation and funding history, request access »

Visikol Comparisons

HQ Location
Total Raised
Post Valuation
Last Financing Details
Developer of tissue clearing and 3D imaging technology designed to accelerate drug discovery. The company's technology i
Drug Discovery
Hampton, NJ
12 As of 2021
0.00 0000-00-00
000000&0 00000


incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ull
Orlando, FL
00 As of 0000
000000000 -


a pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt molli
Schlieren, Switzerland
00 As of 0000
000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Visikol Competitors (15)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Hesperos Accelerator/Incubator Backed Orlando, FL 00 000000000 -
00000000 Formerly VC-backed Schlieren, Switzerland 00 000.00 000000000 000.00
00000000 Formerly VC-backed San Diego, CA 00 0000 000000&0
0000000 Private Equity-Backed Kulmbach, Germany 00 000000000000
0000000 000000000 Venture Capital-Backed San Francisco, CA 00 000.00 00000000000 000.00
You’re viewing 5 of 15 competitors. Get the full list »

Visikol Patents

Visikol Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3857200-A1 Detection of biologicals penetration into tissue surrogates Pending 26-Sep-2018 00000000
US-20210382040-A1 Detection of biologicals penetration into tissue surrogates Pending 26-Mar-2018 0000000000
US-20180021285-A1 Method for visualization of calcium containing components in biological systems Abandoned 25-Jul-2016 A61K31/221

Visikol Executive Team (4)

Name Title Board Seat Contact Info
Michael Johnson Ph.D Co-Founder & Chief Executive Officer
Thomas Villani Jr. Chief Science Officer & Co-Founder
Brian Mulhall Director, Corporate Development
You’re viewing 3 of 4 executive team members. Get the full list »

Visikol Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Visikol Former Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Alan Weiss Angel (individual) Minority 000 0000 000000 0
Brian Mulhall Angel (individual) Minority 000 0000 000000 0
Foundation Venture Capital Group Venture Capital Minority 000 0000 000000 0
National Science Foundation Government 000 0000 000000 0
To view Visikol’s complete investors history, request access »